Browse Title Index
Issue | Title | |
Vol 10, No 2 (2014) | National oncology network | Abstract PDF (Polish) |
Krzysztof Warzocha | ||
Vol 11, No 6 (2015) | Neoadjuvant treatment in a patient with HER2-positive breast cancer — a case study and review of recent recommendations | Abstract PDF HTML |
Małgorzata Kruszwicka, Radosław Lisiecki | ||
Vol 15, No 2 (2019) | Neratinib in adjuvant treatment of patients with HER2-positive breast cancer — less is more? | Abstract PDF |
Ewa Cedrych, Ida Cedrych | ||
Vol 16, No 4 (2020) | Neratinib in extended adjuvant therapy for HER2-positive early breast cancer | Abstract PDF |
Tomasz Kubiatowski | ||
Vol 14, No 5 (2018) | Neuroendocrine rectal tumour as a rare aetiology of adult recto-sigmoidal intussusception: case presentation and literature review | Abstract PDF |
Matei Razvan Bratu, Tudor Marinescu, Bogdan Cristea, Bogdan Ionut Diaconescu | ||
Online first | Neuroendocrine rectal tumour as a rare aetiology of adult recto-sigmoidal intussusception: case presentation and literature review | Abstract PDF |
Matei Razvan Bratu, Tudor Marinescu, Bogdan Cristea, Bogdan Ionut Diaconescu | ||
Online first | Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy | Abstract PDF |
Ireneusz Raczyński, Agnieszka Siedlaczek, Joanna Streb, Patryk Zając, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Weronika Radecka, Michał Jurczyk, Barbara Radecka | ||
Online first | ERRATUM: Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy | Abstract |
Ireneusz Raczyński, Agnieszka Siedlaczek, Joanna Streb, Patryk Zając, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Weronika Radecka, Michał Jurczyk, Barbara Radecka | ||
Vol 3, No 5 (2007) | New approach to postoperative adjuvant treatment in non-small-cell lung cancer | Abstract PDF (Polish) |
Maciej Krzakowski | ||
Vol 16, No 6 (2020) | New dosing schedule of pembrolizumab — theoretical basis and scientific evidence | Abstract PDF |
Dorota Szcześ, Piotr Rutkowski | ||
Vol 3, No 1 (2007) | New options in systemic adjuvant therapy of breast cancer | Abstract PDF (Polish) |
Maciej Krzakowski | ||
Vol 18, No 5 (2022) | New scoring system as predictor of 90-day mortality in appendicular skeletal metastases | Abstract PDF HTML |
I Gede Eka Wiratnaya, Hans Kristian Nugraha, I Gusti Ngurah Wien Aryana, Putu Astawa | ||
Vol 13, No 4 (2017) | New treatment options for patients with metastatic colorectal cancer in Poland | Abstract PDF HTML |
Magdalena Krakowska, Piotr Potemski | ||
Vol 19, No 5 (2023) | News and updates in the treatment of localized stage triple-negative breast cancer | Abstract PDF HTML |
Irene Solana López, Juan Antonio Guerra Martínez, Diego Malón Giménez, Laura Rodríguez Lajusticia, Carmen Pantín González, Ana Manuela Martín Fernández de Soignie, Carlos de Zea Luque, Beatriz Losada Vila, Nadia Sánchez Baños, Fátima Escalona Martín, Elia Martínez Moreno, David Gutiérrez Abad, Ignacio Juez Martel, Beatriz Jiménez Munarriz, Julia Calzas Rodríguez | ||
Vol 10, Supp. A (2014) | Niewydolność serca w trakcie leczenia sunitynibem u pacjentki z rozsianym rakiem nerki | Details PDF (Polish) |
Paweł Nurzyński, Ewa Pierzchała, Andrzej Deptała | ||
Vol 19, No 6 (2023) | Niraparib maintenance in newly diagnosed advanced ovarian cancer — review and case series | Abstract PDF HTML |
Martyna Tyszka, Rafał Stec | ||
Vol 15, No 2 (2019) | Nivolumab in the treatment of advanced renal cell carcinoma | Abstract PDF |
Piotr Tomczak, Zuzanna Synowiec | ||
Vol 19, No 4 (2023) | Nivolumab in the treatment of thoracic cancer — new possibilities | Abstract PDF HTML |
Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk | ||
Vol 15, No 1 (2019) | Nivolumab in treatment of renal cell carcinoma during renal replacement therapy | Abstract PDF |
Kamil Konopka | ||
Vol 14, No 4 (2018) | Nivolumab therapy for refractory and relapsed Hodgkin’s lymphoma — case report | Abstract PDF |
Marta Macioch, Piotr Centkowski | ||
Online first | Nivolumab therapy for refractory and relapsed Hodgkin’s lymphoma — case report | Abstract PDF |
Marta Macioch, Piotr Centkowski | ||
Vol 12, No 2 (2016) | Nivolumab — perspectives in cancer treatment | Abstract PDF |
Hanna Koseła, Piotr Rutkowski | ||
Vol 20, No 3 (2024) | Non-drug related costs of treatment with pertuzumab and trastuzumab in HER2-positive breast cancer patients in Poland | Abstract PDF |
Michał Seweryn, Tomasz Banaś, Joanna Augustyńska, Agnieszka Leszczyńska, Paweł M. Potocki | ||
Vol 6, Supp. A (2010) | Non-pegylated liposomal doxorubicin use in the treatment of bilateral breast cancer | Abstract PDF (Polish) |
Monika Nowaczyk | ||
Vol 10, Supp. G (2014) | Non-small lung cancer patent with mutations in EGFR gene — diagnostic case | Abstract PDF (Polish) |
Tomasz Pacuszko | ||
651 - 675 of 1173 Items | << < 22 23 24 25 26 27 28 29 30 31 > >> |